Catalyst Wire Dossier Catalyst Wire Dossier

HPV-16/18 vaccine (GSK 580299)

Human papillomavirus vaccine type 16 and 18 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HPV-16/18 vaccine (GSK 580299), covering 2016-09-12 to 2016-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women [Phase 2]

See pricing